Autres langues ProPhase Labs, Inc.

Actions

PRPH

US74345W2070

Installations et services en soins de santé

Temps Différé OTC Markets 16:03:49 22/09/2026			Varia. 5j.	Varia. 1 janv.
0,0108 ^USD	+1,69%		-28,00%	-97,59%

19/08	ProPhase Labs, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
30/06	ProPhase Labs, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

19/08	ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
09/07	ProPhase Labs : Amendment to Quarterly Report (Form 10-Q/A)
07/07	ProPhase Labs : Amendment to Quarterly Report (Form 10-Q/A)
30/06	ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
01/06	ProPhase Labs, Inc. Auditor Raises 'Going Concern' Doubt
15/04	ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
15/04	ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform
17/03	ProPhase Labs provides business update highlighting advancing Crown Medical collections activity
17/03	ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
19/02	Advanced Biological Laboratories S.A. cancelled the acquisition of ProPhase Labs, Inc. in a reverse merger transaction.
03/02	Prophase Labs, Inc. Initiates Potential Sale or Strategic Partnership of Be-Smart and Advances Crown Medical Collections Initiative
03/02	ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
02/02	Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
26/01	ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
22/01	ProPhase Labs Uplists from Pink Sheets to OTC Market
09/01	Prophase Labs, Inc. Announces Resignation of Warren Hirsch as Member of the Board of Directors, Effective January 5, 2026
07/01	ProPhase Labs, Inc.(NasdaqCM:PRPH) dropped from S&P TMI Index
05/01	ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
02/01	ProPhase Labs, Inc.(OTCPK:PRPH) dropped from NASDAQ Composite Index
19/12	ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger
19/12	ProPhase Labs, Inc. to Declare A Special Cash Dividend
19/12	Advanced Biological Laboratories S.A. signed a non-binding letter of intent to acquire ProPhase Labs, Inc. in a reverse merger transaction.
19/12	ProPhase Labs signs non-binding LOI for proposed reverse merger with Advanced Biological Laboratories
19/12	ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
26/11	Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1